This white paper provides an overview of current practices for the qualification and refinement of small-scale models (SSM) used in the development of biopharmaceutical drug substance manufacturing processes. SSMs are utilized to meet regulatory expectations of:...
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.AcceptPrivacy Policy
